Skip Nav Destination
Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33+ acute myeloid leukemia
Development of hemophagocytic lymphohistiocytosis in triplets infected with HHV-8
The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both “atypical” myeloproliferative disorders and myelodysplastic syndromes
ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases
[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome
Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype
High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver
Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study
Issue Archive
August 15 2005
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
REVIEWS IN TRANSLATIONAL HEMATOLOGY
Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach
Clinical Trials & Observations
CHEMOKINES
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
Clinical Trials & Observations
David Butera,Svetlana Marukian,Amy E. Iwamaye,Edgardo Hembrador,Thomas J. Chambers,Adrian M. Di Bisceglie,Edgar D. Charles,Andrew H. Talal,Ira M. Jacobson,Charles M. Rice,Lynn B. Dustin
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33+ acute myeloid leukemia
Clinical Trials & Observations
Robert J. Arceci,Jane Sande,Beverly Lange,Kevin Shannon,Janet Franklin,Raymond Hutchinson,Terry A. Vik,David Flowers,Richard Aplenc,Mark S. Berger,Matthew L. Sherman,Franklin O. Smith,Irwin Bernstein,Eric L. Sievers
Development of hemophagocytic lymphohistiocytosis in triplets infected with HHV-8
Clinical Trials & Observations
Brief Report
The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both “atypical” myeloproliferative disorders and myelodysplastic syndromes
Clinical Trials & Observations
Brief Report
David P. Steensma,Gordon W. Dewald,Terra L. Lasho,Heather L. Powell,Rebecca F. McClure,Ross L. Levine,D. Gary Gilliland,Ayalew Tefferi
ERRATA
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases
Clinical Trials & Observations
Manfred Rieger,Pier Mannuccio Mannucci,Johanna A. Kremer Hovinga,Andrea Herzog,Gabi Gerstenbauer,Christian Konetschny,Klaus Zimmermann,Inge Scharrer,Flora Peyvandi,Miriam Galbusera,Giuseppe Remuzzi,Martina Böhm,Barbara Plaimauer,Bernhard Lämmle,Friedrich Scheiflinger
IMMUNOBIOLOGY
Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti–DC-SIGN antibody
Paul J. Tacken,I. Jolanda M. de Vries,Karlijn Gijzen,Ben Joosten,Dayang Wu,Russell P. Rother,Susan J. Faas,Cornelis J. A. Punt,Ruurd Torensma,Gosse J. Adema,Carl G. Figdor
The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell–expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches
Cornelia Halin,M. Lucila Scimone,Roberto Bonasio,Jean-Marc Gauguet,Thorsten R. Mempel,Elizabeth Quackenbush,Richard L. Proia,Suzanne Mandala,Ulrich H. von Andrian
Stem cell factor promotes mast cell survival via inactivation of FOXO3a-mediated transcriptional induction and MEK-regulated phosphorylation of the proapoptotic protein Bim
Christine Möller,Jessica Alfredsson,Maria Engström,Hanna Wootz,Zou Xiang,Johan Lennartsson,Jan-Ingvar Jönsson,Gunnar Nilsson
NEOPLASIA
CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16)
Daniel Helbling,Beatrice U. Mueller,Nikolai A. Timchenko,Julian Schardt,Myriam Eyer,David R. Betts,Martine Jotterand,Sandrine Meyer-Monard,Martin F. Fey,Thomas Pabst
[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome
Clinical Trials & Observations
Corinne Haioun,Emmanuel Itti,Alain Rahmouni,Pauline Brice,Jean-Didier Rain,Karim Belhadj,Philippe Gaulard,Laurent Garderet,Eric Lepage,Felix Reyes,Michel Meignan
NFκB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes
Friedrich Feuerhake,Jeffery L. Kutok,Stefano Monti,Wen Chen,Ann S. LaCasce,Giorgio Cattoretti,Paul Kurtin,Geraldine S. Pinkus,Laurence de Leval,Nancy L. Harris,Kerry J. Savage,Donna Neuberg,Thomas M. Habermann,Riccardo Dalla-Favera,Todd R. Golub,Jon C. Aster,Margaret A. Shipp
Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype
Clinical Trials & Observations
Brief Report
Giovanni Cazzaniga,Maria Grazia Dell'Oro,Cristina Mecucci,Emanuela Giarin,Riccardo Masetti,Vincenzo Rossi,Franco Locatelli,Massimo F. Martelli,Giuseppe Basso,Andrea Pession,Andrea Biondi,Brunangelo Falini
PHAGOCYTES
Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils
Alison M. Condliffe,Keith Davidson,Karen E. Anderson,Chris D. Ellson,Tom Crabbe,Klaus Okkenhaug,Bart Vanhaesebroeck,Martin Turner,Louise Webb,Matthias P. Wymann,Emilio Hirsch,Thomas Ruckle,Montserrat Camps,Christian Rommel,Shaun P. Jackson,Edwin R. Chilvers,Len R. Stephens,Phillip T. Hawkins
RED CELLS
Amnionless function is required for cubilin brush-border expression and intrinsic factor-cobalamin (vitamin B12) absorption in vivo
Qianchuan He,Mette Madsen,Adam Kilkenney,Brittany Gregory,Erik I. Christensen,Henrik Vorum,Peter Højrup,Alejandro A. Schäffer,Ewen F. Kirkness,Stephan M. Tanner,Albert de la Chapelle,Urs Giger,Søren K. Moestrup,John C. Fyfe
TRANSPLANTATION
High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver
Clinical Trials & Observations
Julye C. Lavoie,Joseph M. Connors,Gordon L. Phillips,Donna E. Reece,Michael J. Barnett,Donna L. Forrest,Randy D. Gascoyne,Donna E. Hogge,Stephen H. Nantel,John D. Shepherd,Clayton A. Smith,Kevin W. Song,Heather J. Sutherland,Cynthia L. Toze,Nicholas J. S. Voss,Thomas J. Nevill
Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study
Clinical Trials & Observations
Jean-Yves Cahn,John P. Klein,Stephanie J. Lee,Noël Milpied,Didier Blaise,Joseph H. Antin,Véronique Leblond,Norbert Ifrah,Jean-Pierre Jouet,Fausto Loberiza,Olle Ringden,A. John Barrett,Mary M. Horowitz,Gérard Socié
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals